Jump to content

Data:Test.json: Difference between revisions

From Insurer Brain
Browse history interactively
Content deleted Content added
Created page with "{ "company": "Allianz", "price": 150, "active": true }"
 
No edit summary
 
Line 1: Line 1:
{
{
"company": "Allianz",
"company": "AXA",
"price": 150,
"fiscal_year": 2025,
"active": true
"period": "FY",
"release_date": "2026-02-26",
"currency": "EUR",
"sources": [
{
"id": "financial_supplement",
"title": "AXA FY25 Financial Supplement",
"file": "2025/fy/sources/financial_supplement.xlsx"
},
{
"id": "yahoo",
"title": "Yahoo Finance — CS.PA daily close",
"file": ""
}
],
"records": [
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 115524,
"source": "financial_supplement",
"note": "13. Activity indicators!AD8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "P\u0026C",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 58038,
"source": "financial_supplement",
"note": "13. Activity indicators!AE8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Life \u0026 Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 56512,
"source": "financial_supplement",
"note": "13. Activity indicators!AF8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Life",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 37499,
"source": "financial_supplement",
"note": "13. Activity indicators!AH8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 19014,
"source": "financial_supplement",
"note": "13. Activity indicators!AI8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Asset Management",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 875,
"source": "financial_supplement",
"note": "13. Activity indicators!AJ8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Bank",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 99,
"source": "financial_supplement",
"note": "13. Activity indicators!AK8"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "France",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 30598,
"source": "financial_supplement",
"note": "13. Activity indicators!AE19"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "Europe",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 43005,
"source": "financial_supplement",
"note": "13. Activity indicators!AF19"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "AXA XL",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 19277,
"source": "financial_supplement",
"note": "13. Activity indicators!AG19"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "Asia, Africa \u0026 EME-LATAM",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 19925,
"source": "financial_supplement",
"note": "13. Activity indicators!AH19"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "AXA IM",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 875,
"source": "financial_supplement",
"note": "13. Activity indicators!AI19"
},
{
"label": "Gross Written Premiums \u0026 Other Revenues",
"business_line": "Total",
"business_unit": "Transversal \u0026 Other",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 1844,
"source": "financial_supplement",
"note": "13. Activity indicators!AJ19"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 2233,
"source": "financial_supplement",
"note": "13. Activity indicators!AD10"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Life \u0026 Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 2233,
"source": "financial_supplement",
"note": "13. Activity indicators!AF10"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Life",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 1747,
"source": "financial_supplement",
"note": "13. Activity indicators!AH10"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 486,
"source": "financial_supplement",
"note": "13. Activity indicators!AI10"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Total",
"business_unit": "France",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 695,
"source": "financial_supplement",
"note": "13. Activity indicators!AE21"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Total",
"business_unit": "Europe",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 578,
"source": "financial_supplement",
"note": "13. Activity indicators!AF21"
},
{
"label": "IFRS17/9 New Business Value (NBV)",
"business_line": "Total",
"business_unit": "Asia, Africa \u0026 EME-LATAM",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 959,
"source": "financial_supplement",
"note": "13. Activity indicators!AH21"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 2199,
"source": "financial_supplement",
"note": "13. Activity indicators!AD11"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Life \u0026 Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 2199,
"source": "financial_supplement",
"note": "13. Activity indicators!AF11"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Life",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 1822,
"source": "financial_supplement",
"note": "13. Activity indicators!AH11"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 377,
"source": "financial_supplement",
"note": "13. Activity indicators!AI11"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Total",
"business_unit": "France",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 431,
"source": "financial_supplement",
"note": "13. Activity indicators!AE22"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Total",
"business_unit": "Europe",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 740,
"source": "financial_supplement",
"note": "13. Activity indicators!AF22"
},
{
"label": "New Business Contractual Service Margin (NB CSM)",
"business_line": "Total",
"business_unit": "Asia, Africa \u0026 EME-LATAM",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 1028,
"source": "financial_supplement",
"note": "13. Activity indicators!AH22"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 49357,
"source": "financial_supplement",
"note": "13. Activity indicators!AD14"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Life \u0026 Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 49357,
"source": "financial_supplement",
"note": "13. Activity indicators!AF14"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Life",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 37103,
"source": "financial_supplement",
"note": "13. Activity indicators!AH14"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 12254,
"source": "financial_supplement",
"note": "13. Activity indicators!AI14"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Total",
"business_unit": "France",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 22858,
"source": "financial_supplement",
"note": "13. Activity indicators!AE25"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Total",
"business_unit": "Europe",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 12651,
"source": "financial_supplement",
"note": "13. Activity indicators!AF25"
},
{
"label": "Present Value of Expected Premiums (PVEP)",
"business_line": "Total",
"business_unit": "Asia, Africa \u0026 EME-LATAM",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 13847,
"source": "financial_supplement",
"note": "13. Activity indicators!AH25"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.045,
"source": "financial_supplement",
"note": "13. Activity indicators!AD15"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Life \u0026 Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.045,
"source": "financial_supplement",
"note": "13. Activity indicators!AF15"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Life",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.047,
"source": "financial_supplement",
"note": "13. Activity indicators!AH15"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Health",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.04,
"source": "financial_supplement",
"note": "13. Activity indicators!AI15"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Total",
"business_unit": "France",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.03,
"source": "financial_supplement",
"note": "13. Activity indicators!AE26"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Total",
"business_unit": "Europe",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.046,
"source": "financial_supplement",
"note": "13. Activity indicators!AF26"
},
{
"label": "IFRS17/9 NBV Margin",
"business_line": "Total",
"business_unit": "Asia, Africa \u0026 EME-LATAM",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.069,
"source": "financial_supplement",
"note": "13. Activity indicators!AH26"
},
{
"label": "Total Assets",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 635.5,
"source": "financial_supplement",
"note": "14. Balance Sheet!D24"
},
{
"label": "Goodwill",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 17.8,
"source": "financial_supplement",
"note": "14. Balance Sheet!D8"
},
{
"label": "Other intangible assets",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 4.4,
"source": "financial_supplement",
"note": "14. Balance Sheet!D9"
},
{
"label": "Shareholders' Equity group share",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 47.2,
"source": "financial_supplement",
"note": "14. Balance Sheet!I8"
},
{
"label": "Non-controlling Interests",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 2.4,
"source": "financial_supplement",
"note": "14. Balance Sheet!I9"
},
{
"label": "Financing debt",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 15.8,
"source": "financial_supplement",
"note": "14. Balance Sheet!I11"
},
{
"label": "Insurance contract liabilities",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 470.4,
"source": "financial_supplement",
"note": "14. Balance Sheet!I12"
},
{
"label": "Present Value of Future Cash Flows",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 432.6,
"source": "financial_supplement",
"note": "14. Balance Sheet!I13"
},
{
"label": "Risk Adjustment",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 3.1,
"source": "financial_supplement",
"note": "14. Balance Sheet!I15"
},
{
"label": "Contractual Service Margin (closing, pre-tax)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 33253,
"source": "financial_supplement",
"note": "15.CSM Rollforward!I17"
},
{
"label": "Contractual Service Margin (closing, post-tax)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 25864,
"source": "financial_supplement",
"note": "15.CSM Rollforward!I21"
},
{
"label": "Retained Earnings",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 41.4,
"source": "financial_supplement",
"note": "18. Shareholders Equity!D33"
},
{
"label": "Undated Subordinated Debt",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 4.6,
"source": "financial_supplement",
"note": "18. Shareholders Equity!D32"
},
{
"label": "Other Comprehensive Income",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": -6.8,
"source": "financial_supplement",
"note": "18. Shareholders Equity!D28"
},
{
"label": "Book Value per Share",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1,
"value": 24,
"source": "financial_supplement",
"note": "18. Shareholders Equity!D37"
},
{
"label": "Underlying Earnings Before Tax",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 11044,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!F20"
},
{
"label": "Underlying Earnings Group Share",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 8368,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!F24"
},
{
"label": "Subordinated Debt Charges (post-tax)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": -174,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!F36"
},
{
"label": "Underlying Earnings for EPS",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 8195,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!F37"
},
{
"label": "Underlying Earnings Group Share (FY24)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 8078,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!D24"
},
{
"label": "Net Income Group Share",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 9797,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!F34"
},
{
"label": "Combined Ratio",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.906,
"source": "financial_supplement",
"note": "2. UE by LOB and Net Income!K10"
},
{
"label": "Shares Outstanding (period-end)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "count",
"currency": null,
"scale": 1000000,
"value": 2055.38,
"source": "financial_supplement",
"note": "4. Shares \u0026 UEPS!D14"
},
{
"label": "Average Shares Outstanding",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "count",
"currency": null,
"scale": 1000000,
"value": 2124,
"source": "financial_supplement",
"note": "4. Shares \u0026 UEPS!G20"
},
{
"label": "EPS",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1,
"value": 4.53,
"source": "financial_supplement",
"note": "4. Shares \u0026 UEPS!G32"
},
{
"label": "Underlying EPS",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1,
"value": 3.86,
"source": "financial_supplement",
"note": "4. Shares \u0026 UEPS!G33"
},
{
"label": "Net Income ROE",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.188,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D7"
},
{
"label": "Average Adjusted Shareholders' Equity",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 51.3,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D9"
},
{
"label": "Underlying ROE",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.16,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D11"
},
{
"label": "Debt Gearing",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.223,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D34"
},
{
"label": "Financing Debt (senior)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 3.2,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D19"
},
{
"label": "Dated Subordinated Debt",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 12.6,
"source": "financial_supplement",
"note": "19. ROE\u0026Gearing!D22"
},
{
"label": "Eligible Own Funds",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 56.37036554258047,
"source": "financial_supplement",
"note": "20. Information on Solvency II!J8"
},
{
"label": "Solvency Capital Requirement",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 25.151489436767747,
"source": "financial_supplement",
"note": "20. Information on Solvency II!J9"
},
{
"label": "Solvency II Ratio",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 2.241233692513468,
"source": "financial_supplement",
"note": "20. Information on Solvency II!J10"
},
{
"label": "Holdings Underlying Earnings",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": -1180,
"source": "financial_supplement",
"note": "12. Holdings!I15"
},
{
"label": "Closing Cash Balance at AXA SA",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 5.6,
"source": "financial_supplement",
"note": "12. Holdings!I29"
},
{
"label": "Net cash remittance from subsidiaries",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 7.5,
"source": "financial_supplement",
"note": "12. Holdings!I19"
},
{
"label": "Dividends",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 4.6,
"source": "financial_supplement",
"note": "12. Holdings!I23"
},
{
"label": "Share buy-backs",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000000,
"value": 4.7,
"source": "financial_supplement",
"note": "12. Holdings!I24"
},
{
"label": "Insurance Revenues (P\u0026C)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1000000,
"value": 57656,
"source": "financial_supplement",
"note": "5. P\u0026C UE by Sub LOB!F9"
},
{
"label": "Current Accident Year Loss Ratio",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.669,
"source": "financial_supplement",
"note": "5. P\u0026C UE by Sub LOB!F10"
},
{
"label": "Prior Year Reserve Development Ratio",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": -0.011,
"source": "financial_supplement",
"note": "5. P\u0026C UE by Sub LOB!F14"
},
{
"label": "Expense Ratio (P\u0026C)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "ratio",
"currency": null,
"scale": 1,
"value": 0.248,
"source": "financial_supplement",
"note": "5. P\u0026C UE by Sub LOB!F15"
},
{
"label": "Share price (period-end)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1,
"value": 38.6445,
"source": "yahoo",
"note": "CS.PA close 2025-12-31"
},
{
"label": "Share price (period-average)",
"business_line": "Total",
"business_unit": "Group",
"fiscal_year": 2025,
"period": "FY",
"measure": "monetary",
"currency": "EUR",
"scale": 1,
"value": 36.7633,
"source": "yahoo",
"note": "CS.PA avg 2025-01-01..2025-12-31"
}
]
}
}

Latest revision as of 20:47, 19 June 2026

company"AXA"
fiscal_year2025
period"FY"
release_date"2026-02-26"
currency"EUR"
sources
id"financial_supplement"
title"AXA FY25 Financial Supplement"
file"2025/fy/sources/financial_supplement.xlsx"
id"yahoo"
title"Yahoo Finance — CS.PA daily close"
file""
records
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value115524
source"financial_supplement"
note"13. Activity indicators!AD8"
label"Gross Written Premiums & Other Revenues"
business_line"P&C"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value58038
source"financial_supplement"
note"13. Activity indicators!AE8"
label"Gross Written Premiums & Other Revenues"
business_line"Life & Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value56512
source"financial_supplement"
note"13. Activity indicators!AF8"
label"Gross Written Premiums & Other Revenues"
business_line"Life"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value37499
source"financial_supplement"
note"13. Activity indicators!AH8"
label"Gross Written Premiums & Other Revenues"
business_line"Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value19014
source"financial_supplement"
note"13. Activity indicators!AI8"
label"Gross Written Premiums & Other Revenues"
business_line"Asset Management"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value875
source"financial_supplement"
note"13. Activity indicators!AJ8"
label"Gross Written Premiums & Other Revenues"
business_line"Bank"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value99
source"financial_supplement"
note"13. Activity indicators!AK8"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"France"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value30598
source"financial_supplement"
note"13. Activity indicators!AE19"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"Europe"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value43005
source"financial_supplement"
note"13. Activity indicators!AF19"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"AXA XL"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value19277
source"financial_supplement"
note"13. Activity indicators!AG19"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"Asia, Africa & EME-LATAM"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value19925
source"financial_supplement"
note"13. Activity indicators!AH19"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"AXA IM"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value875
source"financial_supplement"
note"13. Activity indicators!AI19"
label"Gross Written Premiums & Other Revenues"
business_line"Total"
business_unit"Transversal & Other"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value1844
source"financial_supplement"
note"13. Activity indicators!AJ19"
label"IFRS17/9 New Business Value (NBV)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value2233
source"financial_supplement"
note"13. Activity indicators!AD10"
label"IFRS17/9 New Business Value (NBV)"
business_line"Life & Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value2233
source"financial_supplement"
note"13. Activity indicators!AF10"
label"IFRS17/9 New Business Value (NBV)"
business_line"Life"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value1747
source"financial_supplement"
note"13. Activity indicators!AH10"
label"IFRS17/9 New Business Value (NBV)"
business_line"Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value486
source"financial_supplement"
note"13. Activity indicators!AI10"
label"IFRS17/9 New Business Value (NBV)"
business_line"Total"
business_unit"France"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value695
source"financial_supplement"
note"13. Activity indicators!AE21"
label"IFRS17/9 New Business Value (NBV)"
business_line"Total"
business_unit"Europe"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value578
source"financial_supplement"
note"13. Activity indicators!AF21"
label"IFRS17/9 New Business Value (NBV)"
business_line"Total"
business_unit"Asia, Africa & EME-LATAM"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value959
source"financial_supplement"
note"13. Activity indicators!AH21"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value2199
source"financial_supplement"
note"13. Activity indicators!AD11"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Life & Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value2199
source"financial_supplement"
note"13. Activity indicators!AF11"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Life"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value1822
source"financial_supplement"
note"13. Activity indicators!AH11"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value377
source"financial_supplement"
note"13. Activity indicators!AI11"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Total"
business_unit"France"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value431
source"financial_supplement"
note"13. Activity indicators!AE22"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Total"
business_unit"Europe"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value740
source"financial_supplement"
note"13. Activity indicators!AF22"
label"New Business Contractual Service Margin (NB CSM)"
business_line"Total"
business_unit"Asia, Africa & EME-LATAM"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value1028
source"financial_supplement"
note"13. Activity indicators!AH22"
label"Present Value of Expected Premiums (PVEP)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value49357
source"financial_supplement"
note"13. Activity indicators!AD14"
label"Present Value of Expected Premiums (PVEP)"
business_line"Life & Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value49357
source"financial_supplement"
note"13. Activity indicators!AF14"
label"Present Value of Expected Premiums (PVEP)"
business_line"Life"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value37103
source"financial_supplement"
note"13. Activity indicators!AH14"
label"Present Value of Expected Premiums (PVEP)"
business_line"Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value12254
source"financial_supplement"
note"13. Activity indicators!AI14"
label"Present Value of Expected Premiums (PVEP)"
business_line"Total"
business_unit"France"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value22858
source"financial_supplement"
note"13. Activity indicators!AE25"
label"Present Value of Expected Premiums (PVEP)"
business_line"Total"
business_unit"Europe"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value12651
source"financial_supplement"
note"13. Activity indicators!AF25"
label"Present Value of Expected Premiums (PVEP)"
business_line"Total"
business_unit"Asia, Africa & EME-LATAM"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value13847
source"financial_supplement"
note"13. Activity indicators!AH25"
label"IFRS17/9 NBV Margin"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.045
source"financial_supplement"
note"13. Activity indicators!AD15"
label"IFRS17/9 NBV Margin"
business_line"Life & Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.045
source"financial_supplement"
note"13. Activity indicators!AF15"
label"IFRS17/9 NBV Margin"
business_line"Life"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.047
source"financial_supplement"
note"13. Activity indicators!AH15"
label"IFRS17/9 NBV Margin"
business_line"Health"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.04
source"financial_supplement"
note"13. Activity indicators!AI15"
label"IFRS17/9 NBV Margin"
business_line"Total"
business_unit"France"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.03
source"financial_supplement"
note"13. Activity indicators!AE26"
label"IFRS17/9 NBV Margin"
business_line"Total"
business_unit"Europe"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.046
source"financial_supplement"
note"13. Activity indicators!AF26"
label"IFRS17/9 NBV Margin"
business_line"Total"
business_unit"Asia, Africa & EME-LATAM"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.069
source"financial_supplement"
note"13. Activity indicators!AH26"
label"Total Assets"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value635.5
source"financial_supplement"
note"14. Balance Sheet!D24"
label"Goodwill"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value17.8
source"financial_supplement"
note"14. Balance Sheet!D8"
label"Other intangible assets"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value4.4
source"financial_supplement"
note"14. Balance Sheet!D9"
label"Shareholders' Equity group share"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value47.2
source"financial_supplement"
note"14. Balance Sheet!I8"
label"Non-controlling Interests"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value2.4
source"financial_supplement"
note"14. Balance Sheet!I9"
label"Financing debt"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value15.8
source"financial_supplement"
note"14. Balance Sheet!I11"
label"Insurance contract liabilities"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value470.4
source"financial_supplement"
note"14. Balance Sheet!I12"
label"Present Value of Future Cash Flows"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value432.6
source"financial_supplement"
note"14. Balance Sheet!I13"
label"Risk Adjustment"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value3.1
source"financial_supplement"
note"14. Balance Sheet!I15"
label"Contractual Service Margin (closing, pre-tax)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value33253
source"financial_supplement"
note"15.CSM Rollforward!I17"
label"Contractual Service Margin (closing, post-tax)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value25864
source"financial_supplement"
note"15.CSM Rollforward!I21"
label"Retained Earnings"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value41.4
source"financial_supplement"
note"18. Shareholders Equity!D33"
label"Undated Subordinated Debt"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value4.6
source"financial_supplement"
note"18. Shareholders Equity!D32"
label"Other Comprehensive Income"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value-6.8
source"financial_supplement"
note"18. Shareholders Equity!D28"
label"Book Value per Share"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1
value24
source"financial_supplement"
note"18. Shareholders Equity!D37"
label"Underlying Earnings Before Tax"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value11044
source"financial_supplement"
note"2. UE by LOB and Net Income!F20"
label"Underlying Earnings Group Share"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value8368
source"financial_supplement"
note"2. UE by LOB and Net Income!F24"
label"Subordinated Debt Charges (post-tax)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value-174
source"financial_supplement"
note"2. UE by LOB and Net Income!F36"
label"Underlying Earnings for EPS"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value8195
source"financial_supplement"
note"2. UE by LOB and Net Income!F37"
label"Underlying Earnings Group Share (FY24)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value8078
source"financial_supplement"
note"2. UE by LOB and Net Income!D24"
label"Net Income Group Share"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value9797
source"financial_supplement"
note"2. UE by LOB and Net Income!F34"
label"Combined Ratio"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.906
source"financial_supplement"
note"2. UE by LOB and Net Income!K10"
label"Shares Outstanding (period-end)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"count"
currencynull
scale1000000
value2055.38
source"financial_supplement"
note"4. Shares & UEPS!D14"
label"Average Shares Outstanding"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"count"
currencynull
scale1000000
value2124
source"financial_supplement"
note"4. Shares & UEPS!G20"
label"EPS"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1
value4.53
source"financial_supplement"
note"4. Shares & UEPS!G32"
label"Underlying EPS"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1
value3.86
source"financial_supplement"
note"4. Shares & UEPS!G33"
label"Net Income ROE"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.188
source"financial_supplement"
note"19. ROE&Gearing!D7"
label"Average Adjusted Shareholders' Equity"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value51.3
source"financial_supplement"
note"19. ROE&Gearing!D9"
label"Underlying ROE"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.16
source"financial_supplement"
note"19. ROE&Gearing!D11"
label"Debt Gearing"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.223
source"financial_supplement"
note"19. ROE&Gearing!D34"
label"Financing Debt (senior)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value3.2
source"financial_supplement"
note"19. ROE&Gearing!D19"
label"Dated Subordinated Debt"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value12.6
source"financial_supplement"
note"19. ROE&Gearing!D22"
label"Eligible Own Funds"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value56.37036554258047
source"financial_supplement"
note"20. Information on Solvency II!J8"
label"Solvency Capital Requirement"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value25.151489436767747
source"financial_supplement"
note"20. Information on Solvency II!J9"
label"Solvency II Ratio"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value2.241233692513468
source"financial_supplement"
note"20. Information on Solvency II!J10"
label"Holdings Underlying Earnings"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value-1180
source"financial_supplement"
note"12. Holdings!I15"
label"Closing Cash Balance at AXA SA"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value5.6
source"financial_supplement"
note"12. Holdings!I29"
label"Net cash remittance from subsidiaries"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value7.5
source"financial_supplement"
note"12. Holdings!I19"
label"Dividends"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value4.6
source"financial_supplement"
note"12. Holdings!I23"
label"Share buy-backs"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000000
value4.7
source"financial_supplement"
note"12. Holdings!I24"
label"Insurance Revenues (P&C)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1000000
value57656
source"financial_supplement"
note"5. P&C UE by Sub LOB!F9"
label"Current Accident Year Loss Ratio"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.669
source"financial_supplement"
note"5. P&C UE by Sub LOB!F10"
label"Prior Year Reserve Development Ratio"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value-0.011
source"financial_supplement"
note"5. P&C UE by Sub LOB!F14"
label"Expense Ratio (P&C)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"ratio"
currencynull
scale1
value0.248
source"financial_supplement"
note"5. P&C UE by Sub LOB!F15"
label"Share price (period-end)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1
value38.6445
source"yahoo"
note"CS.PA close 2025-12-31"
label"Share price (period-average)"
business_line"Total"
business_unit"Group"
fiscal_year2025
period"FY"
measure"monetary"
currency"EUR"
scale1
value36.7633
source"yahoo"
note"CS.PA avg 2025-01-01..2025-12-31"
Retrieved from "https://www.insurerbrain.com/w/index.php?title=Data:Test.json&oldid=23402"